Secondary outcome measures are time to death , 28-day and 180-day mortality , persistent organ dysfunction combined with death , days alive and free of mechanical ventilation and renal replacement therapy , bloodstream infection in the ICU , length of stay in the ICU and in hospital , proportion of patients with febrile non-haemolytic transfusion reactions , and quality of life at Day 180 .